Skip to content

Clinical trials

Recruiting Hyperinsulinism trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperinsulinism Status: Recruiting Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20171
20201
20221
20231
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Columbia University3
Ali Chappell1
Colorado State University1
Cook Children's Health Care System1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Rezolute1
SynDevRx, Inc.1
Washington University School of Medicine1
Yale University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperinsulinism11
Insulin Resistance6
Obesity4
Hypoglycemia3
Insulinoma3
Breast Neoplasms2
Diabetes Mellitus, Type 22
Glucose Metabolism Disorders2
Non-alcoholic Fatty Liver Disease2
Overweight2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.